Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery, today announced 80% completion of ...
Nature

Advances in the development of new tuberculosis drugs and treatment regimens

Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid, rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to cause ...
USA Today

Even when you don't have TB symptoms, this century-old test can still detect the disease.

Tuberculosis, or TB, is a disease that infects nearly 11 million people worldwide, killing some 1.25 million of them every year, per data from the World Health Organization. A person infected with the ...
clinicaladvisor.com

The Fine Art of Administering a Tuberculin Skin Test

The following scenario emphasizes the necessity of creating a wheal while administering the Mantoux test. A 46-year-old Asian man who recently immigrated to the United States was seen for routine ...
PBS

Tuberculosis was once a disease in decline, but a resurgence in cases has health officials puzzled

An outbreak of tuberculosis, or TB – a lung disease that is often accompanied by a hacking cough – began in January 2024 in Kansas City, Kansas, and two nearby counties and continues as of early March ...
Business Wire

Two PPD Senior Leaders Recognized for Life Sciences Industry Leadership

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq:PPD) today announced that two PPD senior leaders have been named to the 2020 PharmaVOICE 100 list of the most inspiring people in the life sciences ...